GlassScriptPhysician profile
Elaheh Johnson
NPI 1124347851
$2,537.59
in general payments reported to CMS, 2019-2025
28 companies · $33.27 in 2025
The $33.27 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $773 · 2022: $595 · 2023: $664 · 2024: $473 · 2025: $33.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $605.87 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $230.36 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $209.07 | 2021-2022 | |
| Amarin Pharma, INC. | $177.65 | 2021-2023 | |
| Amgen INC. | $152.06 | 2021-2023 | Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $132.91 | 2021-2022 | |
| Tactile Systems Technology INC | $129.37 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Hologic INC | $118.33 | 2022 | |
| Janssen Pharmaceuticals, INC | $93.86 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $82.31 | 2022-2024 | Wegovy |
| Pfizer INC. | $73.61 | 2021 | |
| Eisai INC. | $64.45 | 2021-2024 | |
| Esperion Therapeutics, INC. | $59.51 | 2021-2025 | Nexletol |
| Hikma Pharmaceuticals USA | $51.88 | 2023 | Ryaltris |
| Exact Sciences Corporation | $46.39 | 2023-2024 | Cologuard Collection Kit |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $40.52 | 2021 | |
| Vivus LLC | $37.49 | 2021-2023 | Qsymia |
| Renalytix Ai, INC. | $33.43 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.02 | 2022 | |
| Medtronic, INC. | $23.28 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.13 | 2021 | |
| Menarini Silicon Biosystems, INC. | $19.75 | 2023 | Cellsearch |
| Idorsia Pharmaceuticals US INC | $18.90 | 2023 | Quviviq |
| Amneal Pharmaceuticals LLC | $17.95 | 2022 | |
| Phathom Pharmaceuticals, INC. | $17.88 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $17.45 | 2023 | Verquvo, Belsomra, Steglatro |
| Genentech USA, INC. | $16.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaheh Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.